.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Epigenetic age acceleration has emerged as a significant biomarker in the study of biological aging and cognitive decline. Researchers recently investigated how these molecular clocks correlate with structural brain changes. They specifically focused on older women to determine if epigenetic metrics could predict future neurodegeneration. Consequently, the findings suggest that while most clocks do not mirror brain atrophy patterns, specific measures like AgeAccelGrim2 provide unique insights into Alzheimer's risk.
The study analyzed 1,196 older women over an average period of eight years. Scientists measured five different epigenetic clocks at baseline and compared them with MRI-derived scores. These included the Spatial Pattern of Atrophy for Recognition of Brain Aging (SPARE-BA) and the Alzheimer's Disease Pattern Similarity Score (AD-PS). Notably, most clocks showed no direct association with accelerated brain aging based on SPARE-BA. However, AgeAccelGrim2 demonstrated a statistically significant link with the AD-PS score.
Further analysis revealed that the association between AgeAccelGrim2 and brain changes was quite specific. This link was primarily driven by DNA methylation markers related to smoking history. Furthermore, these changes appeared in the frontal and temporal lobes rather than the hippocampus. This suggests that AgeAccelGrim2 captures neurodegenerative changes specifically associated with lifestyle factors like smoking. Therefore, it may serve as a predictor for dementia risk distinct from traditional Alzheimer's pathways.
Interestingly, the lack of correlation between other clocks and brain volumes indicates that epigenetic and brain age capture different biological processes. Clinical practitioners should note that molecular aging in the blood may not always reflect structural changes in the brain. Nevertheless, using AgeAccelGrim2 could help identify patients at higher risk for smoking-related neurodegeneration. Future research must determine if these biomarkers can guide preventative interventions in geriatric populations.
AgeAccelGrim2 is unique because it incorporates DNA methylation markers of plasma proteins and lifestyle factors like smoking. This makes it a stronger predictor of mortality and specific neurodegenerative patterns compared to first-generation epigenetic clocks.
While it indicates biological aging, it may not reflect early Alzheimer's changes in the hippocampus. Instead, it seems more predictive of atrophy in the frontal and temporal lobes, often linked to vascular and lifestyle-related risks.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
1. McEvoy LK et al. Association of epigenetic age acceleration with MRI biomarkers of aging and Alzheimer's disease neurodegeneration. Aging (Albany NY). 2026 Apr 07. doi: 10.18632/aging.206369. PMID: 41949889.
2. Lu AT, et al. DNA methylation GrimAge strongly predicts lifespan and healthspan. Aging. 2019;11(2):303-327. doi: 10.18632/aging.101684.
3. Hillary RF, et al. Epigenetic measures of ageing and brain health at age 73. Molecular Psychiatry. 2021;26(10):5725-5735. doi: 10.1038/s41380-021-01124-7.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A study explores the link between epigenetic clocks and MRI biomarkers of Alzheimer's, finding that AgeAccelGrim2 predicts neurodegeneration....
3 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
